New Clinical Syndromes in Dermatology

Paolo Romanelli, Navid Bouzari

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Dermatologists are in the unique position to be able to diagnose serious systemic diseases through skin findings; in addition, cutaneous manifestations can be associated with internal symptoms and clarify the pathogenesis and treatment of challenging new syndromes. Calciphylaxix, now renamed Calcific Uremic Arteriolopathy, primarily affects patients with end-stage renal disease with concomitant hyperphosphatemia, increased calcium-phosphate product and hyperparathyroidism, skin biopsy and wound care are crucial parts of the diagnosis and treatment. Hyperhomocysteinemia may play a very important role in many cutaneous and systemic diseases including, chronic cutaneous wounds, systemic lupus erythematosus, Behcet's disease and psoriasis. Through a skin biopsy and biochemical analysis of the proteoglycans accumulation it may be possible to diagnose a new systemic mucinosis and prevent sudden death in patients with severe mitral valve prolapse. Nephrogenic Fibrosing Dermopathy is a newly described fibrosing disorder occurring in patients with end stage renal disease, the etiology and pathogenesis are still unknown, and the ultimate course of this disease has not been defined.

Original languageEnglish (US)
Pages (from-to)79-86
Number of pages8
JournalSeminars in cutaneous medicine and surgery
Issue number2
StatePublished - Jun 1 2006

ASJC Scopus subject areas

  • Surgery
  • Dermatology


Dive into the research topics of 'New Clinical Syndromes in Dermatology'. Together they form a unique fingerprint.

Cite this